EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets

Maija Dambrova, Cristiane Cecatto, Reinis Vilšķe̅rsts, Liepinsh, Edgars

Bioenergetics Communications · 01.01.2022

DOI: 10.26124/bec:2022-0015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioenergetics Communications, erschienen am 01.01.2022. Verfasst von Maija Dambrova und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acylcarnitines are esters of L-carnitine that emerge from the fatty acid metabolism pathways in mitochondria and peroxisomes. Metabolomic profiling assays that investigate disease and nutrition states often include measurements of different acylcarnitines. This has resulted in increased interest regarding the consequences of increased/decreased levels of plasma acylcarnitine concentrations and the mechanisms associated with these changes. Altered acylcarnitine metabolome is characteristic of certain inborn errors of fatty acid metabolism, as well as cardiovascular, metabolic, and neurological diseases in addition to some forms of cancer. Long-chain acylcarnitines accumulate under conditions of insufficient mitochondrial functionality reaching tissue levels that can affect enzyme and ion channel activities, and impact energy metabolism pathways and cellular homeostasis. A better understanding of biochemical and molecular mechanisms behind the changes in acylcarnitine levels and their physiological and pathological roles forms the basis for future therapeutic target selection and preclinical drug discovery, as well as explains off-target effects of some clinically used drugs.

Schlagwörter

acylcarnitinesL-carnitinemitochondrial metabolismfatty acid metabolismperoxisomescardiovascular diseasemetabolic disordersneurological disorderscancertherapeutic target

Zitieren

APA

Dambrova, M., Cecatto, C., Vilšķe̅rsts, R., Liepinsh, & Edgars (2022). Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets. Bioenergetics Communications. https://doi.org/10.26124/bec:2022-0015

Vancouver

Dambrova M, Cecatto C, Vilšķe̅rsts R, Liepinsh, Edgars. Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets. Bioenergetics Communications. 2022. doi:10.26124/bec:2022-0015

BibTeX
@article{Dambrova2022,
  author = {Dambrova, Maija and Cecatto, Cristiane and Vilšķe̅rsts, Reinis and Liepinsh and Edgars},
  title = {Mitochondrial metabolites acylcarnitines: therapeutic potential and drug targets},
  journal = {Bioenergetics Communications},
  year = {2022},
  doi = {10.26124/bec:2022-0015}
}
Kostenlos starten →